Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Shea who wrote (8375)	6/17/1999 3:21:00 PM
From: Trevor Blake	Read Replies (1) \| Respond to of 57584

Kevin, I am a rare poster on this thread. I have only been investing for about a year and I prefer to shut up and learn than offer any inexperienced thoughts. I have always enjoyed your posts and learned a great deal. Thank you for sharing what you know and think. My area of "expertise" is biotech. I hold a long position in HIV (Cel-Sci) and I invested primarily because of their excellent research and phase 1 and ii results with Multikine. Multikine is likely to be a revolutionary cancer drug, especially in head and neck tumors. In a couple of years I think everyone will know about it. Cel Sci also has an HIV vaccine research program underway, through a wholly owned subsidiary. Rarely do they speak of their research results, but this aids vaccine involvement is what attracts most other investors, expecially day-traders... the excitement of a potential Entremed-like gap-up is hard to resist. The stock has been in the doldrums for two years, and while I have been an investor it has bounced around the $2 mark. The only time any life comes into the stock is when Day-traders On-line hypes it. Along comes a swarm of salivating innocents. The price spikes to 3 1/2 and then slowly erodes back to $2. This seems to be happening again. Yesterday HIV was called in DTO and lo and behold the current price is $3. However, something feels different about this move and the charts are taking on a new appearance. There have been large block buys (and sells) and I suspect some European investing is behind the initial large block buys. Trading today is over 1MM, Av volume is <150,000 I would appreciate your TA on the charts. If you think HIV has finally broken its monotonous daily journey, it may be worth everyone taking a closer look. If we could clear away the DTO crowd, things might be clearer. I have always felt this company was undervalued just based on Multikine potential, and if it breaks out it could spike up to $5 or $7 quickly, in my opinion... your thoughts. Be well.